Visionary Ventures

Visionary Ventures is a venture capital fund investing in life sciences, ophthalmology, and medical aesthetics. They focus on early and late-stage investments, from Series A rounds through commercialization, with a target investment range of $5M to $15M. Their unique approach leverages partnerships with Key Opinion Leaders (KOLs) to enhance investment insights and reduce risk.

Visionary Ventures favicon
Founded 2016 ยท venture_capital
Newport Beach (United States)
Investment Stages
series-a
series-b
Portfolio Companies

Aurion Biotech, Centricity Vision, CorneaGen, IanTech, IanTrek, Inc., ONL Therapeutics, Orasis, Pelage Pharmaceuticals, Re-Vana Therapeutics, RxSight, Surface Pharmaceuticals, Sydnexis, Tarsus Pharmaceuticals, Tear Film Innovations, TearClear

Contacts
Unlock contacts with credits
Share this page